I don't either. I suspect the first news will involve the transdermal patch, but I do not see how that can be said by itself. Other details would need to be disclosed informing shareholders who is selling the patches and what type of marketing will be done. How big is the anticipated market? Pricing? Perhaps even a hint about margins so investors can determine a fair share price multiple. Will Univec remain a stand alone company? Financials.....